1675673828
Solutions OP Clinical Trials UK

Advertise on podcast: Solutions OP Clinical Trials UK

This podcast has
65 episodes
Language
English
Publisher
Olga Peycheva
Explicit
No
Date created
2023/03/04
Latest episode
2026/11/06
Average duration
30 min.
Release period
14 days

Description

This podcast is dedicated to clinical trials and clinical research. We will be discussing different hot topics and analysis of the latest developments in clinical trials in pharmaceutical and medical devices industries. We have interviews with different industry experts. New episodes will be available every 2 weeks.

Unlock Solutions OP Clinical Trials UK podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Solutions OP Clinical Trials UK podcast


Should Lack of Capacity Prevent People from Being Part of Clinical Trials?
2026/11/06
This episode is a review of the ethical issues around involving in clinical trials participants who do not have capacity to consent. What are the challenges and safeguarding requirements for vulnerable participants? Could the safeguarding have a negative impact on participants' access to clinical trials and different treatment options? These are some of the questions addressed during the review with Lydia Ainsworth.
How Will AI Reshape the Recruitment in Healthcare: Interview with Harry Henson
2026/10/30
In this episode we are discussing with Harry Henson, the associate director of RBW Consulting, how AI will reshape the healthcare and pharma industry. Is AI making the recruitment process more efficient? Would AI make recruiters redundant? What are the risks for potential candidates being pre-screened using AI? We try to discuss all these questions in a serious but also entertaining way.
What Caused The Global Crisis of Antibiotics Resistance
2026/10/16
In this episode we discuss with Lydia Ainsworth the global antibiotics crisis and the reasons for this crisis. In addition, we mention some of the drug development trends and some ideas how to encourage antibiotics development.
Do We Need Women Participants in Clinical Investigations for Medical Devices
2026/10/02
In this episode we review why we need women to participate in clinical research with medical devices. We also cover the FDA guidance on sex-specific data collection for medical devices and its main recommendations on the study design and data collection requirements.
Dose Optimisation in Radiotherapeutics: The Latest Regulatory Recommendations
2026/09/18
This episode is a review of a white paper from Aug 2026 on dose optimisation for radiotherapeutics. In addition, Lydia Ainsworth reviews the FDA guidance covering the same topic and providing FDA recommendations. The episode contains recommendations on dose selection and study design for clinical trials with radiotherapeutics.
The Ethical Challenges of Clinical Research with Implantable Neural Devices
2026/09/04
In this episode we review with Lydia Ainsworth an article discussing ethical challenges for clinical research with implantable neural devices. The overview provides valuable insights for ethics committees, researchers and manufacturers designing informed consents and investigational plans.
Psychedelics research: Overview of the latest FDA guidance (Jul 2026) and a case study
2026/08/21
This episode is dedicated to psychedelics research. It covers the recommendations from the US FDA guidance from Jul 2026 which clarifies the agency's expectations regarding the drug development and clinical trials design for psychedelics. In addition, there is an overview of the study design of a clinical trial with psilocybin used in treatment-resistant depression.
Health Canada - What is changing in clinical trials regulations?
2026/08/07
This episode covers the upcoming changes in the clinical trial regulations in Canada based on information presented by Health Canada. It also contains global trends analysis and comparison to the regulatory changes in the USA and Europe.
Pharmacovigilance: International Overview of Regulatory Opportunities and Challenges
2026/07/24
This episode is an overview and analysis of the discussions from the 3rd day of the 5th FDA, MHRA and Health Canada Symposium in June 2026. It covers international initiatives for harmonisation of drug safety review among different regulatory agencies, and the use and challenges of AI in pharmacovigilance. In addition, Lydia Ainsworth provides practical perspective of the challenges of collecting drug safety information in clinical trials.
Bioequivalence studies: Inspections and regulators' expectations
2026/07/10
Our latest podcast is dedicated to bioequivalence studies and their specific challenges. We also cover what was discussed in terms of inspection findings, cases studies and expectations by FDA and Health Canada on their recent symposium in June 2026. In addition, Lydia Ainsworth, shares with us her practical experience from site level and monitoring level on common issues with blood sample collections.
What Are The Regulators Perspectives on Clinical Trials Risk Management?
2026/06/26
This episode is review and analysis on the first day of the 5th FDA, MHRA and Health Canada Symposium in June 2026 which covered GCP, clinical trials and risk management.
What Did We Learn From European GCP Inspections
2026/06/12
Clinical trials GCP inspections are common but the expectations can vary between different inspectors and agencies. In this episode, we are discussing with my colleague Lydia Ainsworth, what we learnt during the GCP inspections that we had in Europe in 2025. We cover some key inspection preparation points for the sponsors but also for the hospitals.
How To Improve Clinical Trials Management In The UK: Discussion with Lydia Ainsworth
2026/05/29
This episode is a follow up on round table discussions during the ICR Conference on 13 and 14th of April 2026 in Birmingham. We discuss the common issues related to setting up clinical trials in the UK and also the challenges with adaptation of electronic site files and digital technologies in clinical research. We also provide some recommendations how the processes can be improved and streamlined.
ICR conference, April 2026: The latest on the UK clinical trials regulatory changes
2026/05/15
In this episode we discuss with Lydia Ainsworth, our Senior Clinical Data Quality Manager, what we learnt from the Institute of Clinical Research (ICR) Conference, 13-14 Apr 2026. The conference covered the latest clinical trials regulatory changes which affect the pharma and biotech industry. There were representatives from UK regulators MHRA and HRA, but also from the industry, academia and NHS. You can learn about the clinical trials regulations changes; what is coming in the medical devices' field; the importance of patient engagement; the use of AI in clinical research; latest trends in drug development and other topics. You can read the transcript of the interview here: https://solutionsop.co.uk/2026/05/15/icr-conference-april-2026-the-latest-on-the-uk-clinical-trials-regulatory-changes/
Are Cell And Gene Therapies The Future Of Personalised Treatments
2026/05/01
This is a short overview of the current development of cell and gene therapies and their challenges. It discusses the different types of cell therapies; latest developments and the challenges of creating allogenic cell therapies. Terminology is avoided on purpose to present the information in accessible way for those without scientific background.

Podcast reviews

Read Solutions OP Clinical Trials UK podcast reviews


0 out of 5
0 reviews

Podcast sponsorship advertising

Start advertising on Solutions OP Clinical Trials UK relevant audience podcasts


What do you want to promote?